Sunshine Biopharma, Inc. (SBFM)

NASDAQ: SBFM · IEX Real-Time Price · USD

0.930

+0.040 (4.49%)

At close: May 17, 2024, 4:00 PM

0.920

-0.010 (-1.08%)

After-hours: May 17, 2024, 7:59 PM EDT

Sunshine Biopharma Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013 - 2007
Revenue	24.09	4.35	0.23	0.07	0.02	0	0	0	0	0	Upgrade
Revenue Growth (YoY)	454.42%	1802.41%	219.88%	238.10%	-	-	-	-	-	-	Upgrade
Cost of Revenue	15.75	2.65	0.12	0.03	0.01	0	0	0	0	0	Upgrade
Gross Profit	8.34	1.7	0.11	0.05	0.01	0	0	0	0	0	Upgrade
Selling, General & Admin	10.82	9.46	1.87	0.61	0.62	1.14	0.85	0.9	0.77	1.43	Upgrade
Research & Development	1.86	0.81	0.67	0	0.02	0.01	0	0.03	0.01	0.33	Upgrade
Other Operating Expenses	0.45	18.42	0.01	0.01	0.01	0.01	0.01	0.06	0	0	Upgrade
Operating Expenses	13.12	28.7	2.55	0.62	0.65	1.16	0.86	0.99	0.78	1.76	Upgrade
Operating Income	-4.79	-27	-2.44	-0.58	-0.64	-1.16	-0.86	-0.99	-0.78	-1.76	Upgrade
Interest Expense / Income	0.14	0.04	0.33	0.17	0.12	0.14	0.1	0.03	0.31	0.14	Upgrade
Other Expense / Income	-0.81	-0.53	9.67	2.04	0.9	0.85	0.08	2.47	0.57	0.04	Upgrade
Pretax Income	-4.11	-26.51	-12.44	-2.78	-1.66	-2.16	-1.04	-3.5	-1.65	-1.93	Upgrade
Income Tax	0.4	0.23	0	0	0	0	0	0	0	0	Upgrade
Net Income	-4.51	-26.74	-12.44	-2.78	-1.66	-2.16	-1.04	-3.5	-1.65	-1.93	Upgrade
Shares Outstanding (Basic)	0	0	0	0	0	0	0	0	0	0	Upgrade
Shares Outstanding (Diluted)	0	0	0	0	0	0	0	0	0	0	Upgrade
Shares Change	60.28%	481.18%	155.96%	1765.63%	259.87%	39.45%	105.66%	253.33%	87.50%	14.29%	Upgrade
EPS (Basic)	-19.00	-176.00	-476.00	-273.00	-3000.00	-14200.00	-8000.00	-80000.00	-80000.00	-240000.00	Upgrade
EPS (Diluted)	-19.00	-176.00	-476.00	-273.00	-3000.00	-14200.00	-8000.00	-80000.00	-80000.00	-240000.00	Upgrade
Free Cash Flow	-8.73	-5.41	-1.83	-0.66	-0.5	-0.53	-0.55	-0.32	-0.87	-0.54	Upgrade
Free Cash Flow Per Share	-35.86	-35.63	-70.03	-64.53	-908.56	-3489.93	-5016.57	-5980.55	-57077.99	-65157.88	Upgrade
Gross Margin	34.61%	39.04%	48.42%	63.80%	47.68%	-	-	-	100.00%	-	Upgrade
Operating Margin	-19.86%	-621.33%	-1068.24%	-807.83%	-3037.91%	-	-	-	-45683.67%	-	Upgrade
Profit Margin	-18.70%	-615.44%	-5444.41%	-3898.74%	-7860.85%	-	-	-	-96774.47%	-	Upgrade
Free Cash Flow Margin	-36.22%	-124.47%	-800.75%	-922.13%	-2351.49%	-	-	-	-51079.45%	-	Upgrade
EBITDA	-3.82	-26.45	-12.09	-2.6	-1.53	-1.96	-0.93	-3.4	-1.34	-1.79	Upgrade
EBITDA Margin	-15.87%	-608.58%	-5294.88%	-3643.64%	-7246.89%	-	-	-	-78538.99%	-	Upgrade
Depreciation & Amortization	0.15	0.03	0.01	0.01	0.01	0.05	0.01	0.06	0	0	Upgrade
EBIT	-3.97	-26.47	-12.11	-2.62	-1.54	-2.01	-0.94	-3.46	-1.35	-1.79	Upgrade
EBIT Margin	-16.49%	-609.16%	-5300.46%	-3663.33%	-7312.11%	-	-	-	-78787.88%	-	Upgrade

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).